Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the dry weight of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Metabolic and molecular effects of high-fat diet (HFD). by Ping-yu Cai (12389929)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on ion contents of HHZ and XLY900 at days 10 under saline conditions. by Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on the growth parameters of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on photosynthetic gas exchange parameters of HHZ and XLY900 at days 10 under saline conditions. by Yin Jie (21464235)

Effect of exogenous 1’,4’-<i>trans</i>-diol-ABA on antioxidant system of HHZ and XLY900 at days 0, 1, 4, 7, and 10 under saline conditions. by Yin Jie (21464235)

CaSki cells functionally express VDR and RXR. by Euclides Avila (41023)

Calcitriol inhibits CaSki cell migration and suppresses MMP7 and MMP13 gene expression. by Euclides Avila (41023)

Validation of gene expression changes induced by calcitriol in CaSki cells. by Euclides Avila (41023)

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

RICTOR silencing inhibits cell proliferation via UGCG regulation. by Mohammad Nafees Ansari (22232505)

“…(<b>C</b>) Cell proliferation studies show a decrease in the proliferation of MCF-7_RICTOR^SH cells (mean ± SEM, <i>n</i> = 4) compared to MCF-7_SCRAM^SH cells. …”

Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration. by Masashi Okawa (8951294)

“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Percentage survival of <i>Acinetobacter baumannii</i> infected <i>Galleria mellonella.</i> by Techit Thavorasak (13138440)

Related to Fig 3. by Mohammad Nafees Ansari (22232505)

“…(<b>Q</b>) Tumor growth kinetics recorded a significantly higher growth of BT-474_ZFX^OE (mean ± SEM, <i>n</i> = 5) than BT-474_VECT^OE tumors. …”

IFA did not affect LPS-induced inflammation response. by Tingting Wang (123983)

IFA treatment facilitated host immune clearance of hypervirulent <i>K</i>. <i>pneumoniae</i> by targeting capsule. by Tingting Wang (123983)

IFA effectively limited bacterial dissemination and protected mice from lethal hypervirulent <i>K</i>. <i>pneumoniae</i> pneumonia. by Tingting Wang (123983)